网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
骨质疏松性椎体骨折经皮椎体成形术后邻近椎体骨折的风险因素分析
作者:林永飞  邱崇慧  王志相 
单位:赣州市中医院, 江西 赣州 341000
关键词:骨质疏松性骨折 经皮椎体成形术 邻近椎体骨折 风险因素 
分类号:R683.2
出版年·卷·期(页码):2021·49·第一期(74-78)
摘要:

目的: 探讨影响经皮椎体成形术(PVP)治疗骨质疏松性椎体压缩性骨折(OVCF)后邻近椎体骨折的危险因素,并为临床提供指导。方法: 采用回顾性分析PVP治疗单个OVCF并符合本研究纳入标准的168例患者,分为术后再骨折组与术后保持良好组,随访至少2年的时间,分析再骨折与邻椎风险因素[年龄、性别、胸腰椎骨折节段、体质量指数(BMI)、骨密度T值、骨折类型、注入的骨水泥量、骨水泥分布样式、术前骨折严重程度、术后复位角(Cobb角)]的关系,并进一步建立再塌陷的危险评分。结果: 41例(24.4%)邻椎再骨折患者的BMI、骨密度T值、骨水泥注入量、骨水泥的分布样式以及术后Cobb角与邻椎再骨折的发生显著相关。结论: 根据BMI、骨密度T值、骨水泥注入量、骨水泥的分布样式以及术后Cobb角的矫正等建立的危险因素评分,可有效预测PVP术后邻椎体骨折的风险。

Objective: To investigate the risk factors of adjacent osteoporotic vertebral compression fracture(OVCF)in the treatment of OVCF, and to provide guidance for clinical practice. Methods: A retrospective analysis of percutaneous vertebroplasty(PVP) in the treatment of single OVCF and 168 patients who met the inclusion criteria of this study was followed up for at least 2 years to analyze the risk factors of adjacent vertebrae (age, gender, BMI, bone mineral density T value, fracture type, injected). The amount of bone cement, the distribution pattern of bone cement, the severity of preoperative fracture, the relationship of postoperative Cobb angle, and further establish the risk score of re-collapse. Results: This study found 41 patients (24.4%) with adjacent vertebrae fractures, BMI, bone mineral density T value, bone cement injection volume, bone cement distribution pattern and postoperative Cobb angle correction were significantly correlated with the occurrence of adjacent vertebrae refracture. Conclusion: According to BMI, bone mineral density T value, bone cement injection volume, the risk factor scores established by the distribution pattern of cement and the correction of postoperative Cobb angle can effectively predict the adjacent fractures after PVP.

参考文献:

[1] JOHNELL O,KANIS J A.An estimate of the worldwide prevalence and disability associated with osteoporotic fractures[J].Osteoporos Int,2006,17(12):1726-1733.
[2] BORGSTR M F,SOBOCKI P,STR M O,et al.The societal burden of osteoporosis in Sweden[J].Bone,2007,40(6):1602-1609.
[3] GARFIN S R,YUAN H A,REILEY M A.New technologies in spine:kyphoplasty and vertebroplasty for the treatment of painful osteoporotic compression fractures[J].Spine (Phila Pa 1976),2001,26(14):1511-1515.
[4] ZETHRAEUS N,BORGSTR M F,STR M O,et al.Cost-effectiveness of the treatment and prevention of osteoporosis-a review of the literature and a reference model[J].Osteoporos Int,2007,18(1):9-23.
[5] KIM D H,VACCARO A R.Osteoporotic compression fractures of the spine; current options and considerations for treatment[J].Spine J,2006,6(5):479-487.
[6] SUZUKI N,OGIKUBO O,HANSSON T.The course of the acute vertebral body fragility fracture:its effect on pain,disability and quality of life during 12 months[J].Eur Spine J,2008,17(10):1380-1390.
[7] JANG J S,KIM D Y,LEE S H.Efficacy of percutaneous vertebroplasty in the treatment of intravertebral pseudarthrosis associated with noninfected avascular necrosis of the vertebral body[J].Spine (Phila Pa 1976),2003,28(14):1588-1592.
[8] MASALA S,MASTRANGELI R,PETRELLA M C,et al.Percutaneous vertebroplasty in 1,253 levels:results and long-term effectiveness in a single centre[J].Eur Radiol,2009,19(1):165-171.
[9] 杨茜苑,宋洁富,秦德安.骨质疏松性椎体压缩骨折骨水泥强化术后邻近椎体骨折相关因素研究进展[J].医学综述,2019,25(11):2180-2184.
[10] KAUFMAN J M,PALACIOS S,SILVERMAN S,et al.An evaluation of the Fracture Risk Assessment Tool (FRAX) as an indicator of treatment efficacy:the effects of bazedoxifene and raloxifene on vertebral,nonvertebral,and all clinical fractures as a function of baseline fracture risk assessed by FRAX[J].Osteoporos Int,2013,24(10):2561-2569.
[11] 杨航,彭成忠,曾庆虎,等.单双侧穿刺椎体成形术对邻近椎体骨折影响的比较[J].生物骨科材料与临床研究,2018,15(5):41-44.
[12] TAKAHARA K,KAMIMURA M,MORIYA H,et al.Risk factors of adjacent vertebral collapse after percutaneous vertebroplasty for osteoporotic vertebral fracture in postmenopausal women[J].BMC Musculoskelet Disord,2016,17(12):12.
[13] 蔡金辉,刘庆余,阮耀钦,等.经皮椎体强化术后骨水泥椎间盘渗漏与邻近椎体骨折的相关性分析[J].中国脊柱脊髓杂志,2018,28(8):713-719.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 499961 位访问者


 ©《现代医学》编辑部
联系电话:025-83272481;83272479
电子邮件: xdyx@pub.seu.edu.cn

苏ICP备09058541